| 000 | 01641 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516043615.0 | ||
| 264 | 0 | _c20120702 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1778-7254 | ||
| 024 | 7 |
_a10.1016/j.jbspin.2011.04.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMozzati, Marco | |
| 245 | 0 | 0 |
_aA dental extraction protocol with plasma rich in growth factors (PRGF) in patients on intravenous bisphosphonate therapy: a case-control study. _h[electronic resource] |
| 260 |
_bJoint bone spine _cDec 2011 |
||
| 300 |
_a648-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAdjuvants, Pharmaceutic _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xepidemiology |
| 650 | 0 | 4 |
_aBone Regeneration _xdrug effects |
| 650 | 0 | 4 |
_aBone Resorption _xprevention & control |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTooth Extraction _xmethods |
| 700 | 1 | _aArata, Valentina | |
| 700 | 1 | _aGallesio, Giorgia | |
| 700 | 1 | _aCarossa, Stefano | |
| 773 | 0 |
_tJoint bone spine _gvol. 78 _gno. 6 _gp. 648-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jbspin.2011.04.017 _zAvailable from publisher's website |
| 999 |
_c20957669 _d20957669 |
||